Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrate-mediated vasodilatation
- 31 October 2010
- journal article
- Published by Elsevier BV in Vascular Pharmacology
- Vol. 53 (3-4), 115-121
- https://doi.org/10.1016/j.vph.2010.05.002
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor CellsOncology, 2009
- Gemcitabine: vascular toxicity and prothrombotic potentialExpert Opinion on Drug Safety, 2008
- Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial functionGrowth Factors, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerThe New England Journal of Medicine, 2007
- Differential Toxicity of Anthracyclines on Cultured Endothelial CellsEndothelium, 2004
- ‘Accidental’ anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examplesEuropean Journal of Cancer, 2000
- Suppression of Apoptosis by Inhibition of Phosphatidylcholine-Specific Phospholipase C in Vascular Endothelial CellsEndothelium, 1997
- Mitochondria and programmed cell death: back to the futureFEBS Letters, 1996
- Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemiaThe Lancet, 1992
- Effects of injury and repair of the pulmonary endothelium on lung metastasis after bleomycinThe Journal of Pathology, 1986